Approval · Notice of Compliance 2998 · 1998
INTRON A: Notice of Compliance 2998
Issued January 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2998
- Date
- January 27, 1998
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing site
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INTRON A | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFA 2B 10,000,000 UNIT per ML
- INTERFERON ALFA 2B 3,000,000 UNIT per ML
- INTERFERON ALFA 2B 5,000,000 UNIT per ML